Clinical Trial Update: Cardiac Safety Study in Patients With HER2 + Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 cardiac safety trial in HER2-positive breast cancer evaluated left ventricular function outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Heart Failure
• Left Ventricular Dysfunction

Snippet

Sponsor: Medstar Health Research Institute | Conditions: HER2 Positive Breast Cancer, Left Ventricular Function Systolic Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2021-02-02